MicroRNA signatures in human cancers - PubMed (original) (raw)

Review

doi: 10.1038/nrc1997.

Affiliations

• PMID: 17060945
• DOI: 10.1038/nrc1997

Review

MicroRNA signatures in human cancers

George A Calin et al. Nat Rev Cancer. 2006 Nov.

Abstract

MicroRNA (miRNA) alterations are involved in the initiation and progression of human cancer. The causes of the widespread differential expression of miRNA genes in malignant compared with normal cells can be explained by the location of these genes in cancer-associated genomic regions, by epigenetic mechanisms and by alterations in the miRNA processing machinery. MiRNA-expression profiling of human tumours has identified signatures associated with diagnosis, staging, progression, prognosis and response to treatment. In addition, profiling has been exploited to identify miRNA genes that might represent downstream targets of activated oncogenic pathways, or that target protein-coding genes involved in cancer.

PubMed Disclaimer

Similar articles

• Investigation of microRNA alterations in leukemias and lymphomas.
  Calin GA, Croce CM. Calin GA, et al. Methods Enzymol. 2007;427:193-213. doi: 10.1016/S0076-6879(07)27011-9. Methods Enzymol. 2007. PMID: 17720486
• MicroRNA expression profiling in cancer from a bioinformatics prospective.
  Gusev Y, Brackett DJ. Gusev Y, et al. Expert Rev Mol Diagn. 2007 Nov;7(6):787-92. doi: 10.1586/14737159.7.6.787. Expert Rev Mol Diagn. 2007. PMID: 18020908 Review.
• MicroRNAs and cancer.
  Wijnhoven BP, Michael MZ, Watson DI. Wijnhoven BP, et al. Br J Surg. 2007 Jan;94(1):23-30. doi: 10.1002/bjs.5673. Br J Surg. 2007. PMID: 17205498 Review.
• Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs.
  Wu M, Jolicoeur N, Li Z, Zhang L, Fortin Y, L'Abbe D, Yu Z, Shen SH. Wu M, et al. Carcinogenesis. 2008 Sep;29(9):1710-6. doi: 10.1093/carcin/bgn073. Epub 2008 Mar 19. Carcinogenesis. 2008. PMID: 18356149
• MicroRNA expression profiling using microarrays.
  Liu CG, Calin GA, Volinia S, Croce CM. Liu CG, et al. Nat Protoc. 2008;3(4):563-78. doi: 10.1038/nprot.2008.14. Nat Protoc. 2008. PMID: 18388938

Cited by

• The prognostic value of microRNAs varies with patient race/ethnicity and stage of colorectal cancer.
  Bovell LC, Shanmugam C, Putcha BD, Katkoori VR, Zhang B, Bae S, Singh KP, Grizzle WE, Manne U. Bovell LC, et al. Clin Cancer Res. 2013 Jul 15;19(14):3955-65. doi: 10.1158/1078-0432.CCR-12-3302. Epub 2013 May 29. Clin Cancer Res. 2013. PMID: 23719259 Free PMC article.
• Electron beam-assisted healing of nanopores in magnesium alloys.
  Zheng H, Liu Y, Cao F, Wu S, Jia S, Cao A, Zhao D, Wang J. Zheng H, et al. Sci Rep. 2013;3:1920. doi: 10.1038/srep01920. Sci Rep. 2013. PMID: 23719630 Free PMC article.
• Selective inhibition of miR-21 by phage display screened peptide.
  Bose D, Nahar S, Rai MK, Ray A, Chakraborty K, Maiti S. Bose D, et al. Nucleic Acids Res. 2015 Apr 30;43(8):4342-52. doi: 10.1093/nar/gkv185. Epub 2015 Mar 30. Nucleic Acids Res. 2015. PMID: 25824952 Free PMC article.
• MiR-124 inhibits cell proliferation in breast cancer through downregulation of CDK4.
  Feng T, Xu D, Tu C, Li W, Ning Y, Ding J, Wang S, Yuan L, Xu N, Qian K, Wang Y, Qi C. Feng T, et al. Tumour Biol. 2015 Aug;36(8):5987-97. doi: 10.1007/s13277-015-3275-8. Epub 2015 Mar 3. Tumour Biol. 2015. PMID: 25731732

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database